National Council for Prescription Drug Programs indexing - billing unit
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Label type
- Indexing - Billing Unit
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-05 02:39:46
Label at a glance#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0075-0621-60 | ML - Milliliter | 0075-0621 | c828c607-7484-488e-bb92-e99a78d49e7f | 1 | 2012-07-24 |
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0075-0621 | 0075-0621-60 |
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020164-001 | LOVENOX (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 30MG/0.3ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1993-03-29 |
| N020164-002 | LOVENOX (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 40MG/0.4ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-01-30 |
| N020164-003 | LOVENOX (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 60MG/0.6ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-03-27 |
| N020164-004 | LOVENOX (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 80MG/0.8ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-03-27 |
| N020164-005 | LOVENOX (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 100MG/ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 1998-03-27 |
| N020164-006 | LOVENOX (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 90MG/0.6ML (150MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / SUBCUTANEOUS | RLD | 2000-06-02 | |
| N020164-007 | LOVENOX (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 120MG/0.8ML (150MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 2000-06-02 |
| N020164-008 | LOVENOX (PRESERVATIVE FREE) | ENOXAPARIN SODIUM | 150MG/ML (150MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 2000-06-02 |
| N020164-009 | LOVENOX | ENOXAPARIN SODIUM | 300MG/3ML (100MG/ML) | INJECTABLE / INTRAVENOUS, SUBCUTANEOUS | AB | RLD | 2003-01-23 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N020164-001 | AP |
| N020164-002 | AP |
| N020164-003 | AP |
| N020164-004 | AP |
| N020164-005 | AP |
| N020164-007 | AP |
| N020164-008 | AP |
| N020164-009 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N020164-001 | LOVENOX (PRESERVATIVE FREE) | 30MG/0.3ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1993-03-29 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020164-002 | LOVENOX (PRESERVATIVE FREE) | 40MG/0.4ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-01-30 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020164-003 | LOVENOX (PRESERVATIVE FREE) | 60MG/0.6ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-03-27 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020164-004 | LOVENOX (PRESERVATIVE FREE) | 80MG/0.8ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-03-27 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020164-005 | LOVENOX (PRESERVATIVE FREE) | 100MG/ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 1998-03-27 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020164-006 | LOVENOX (PRESERVATIVE FREE) | 90MG/0.6ML (150MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / SUBCUTANEOUS | RLD | 2000-06-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N020164-007 | LOVENOX (PRESERVATIVE FREE) | 120MG/0.8ML (150MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 2000-06-02 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020164-008 | LOVENOX (PRESERVATIVE FREE) | 150MG/ML (150MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 2000-06-02 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020164-009 | LOVENOX | 300MG/3ML (100MG/ML) | INJECTABLE / INTRAVENOUS, SUBCUTANEOUS | AB | RLD | 2003-01-23 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-001 | LOVENOX (PRESERVATIVE FREE) | 30MG/0.3ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1993-03-29 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-002 | LOVENOX (PRESERVATIVE FREE) | 40MG/0.4ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-01-30 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-003 | LOVENOX (PRESERVATIVE FREE) | 60MG/0.6ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-03-27 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-004 | LOVENOX (PRESERVATIVE FREE) | 80MG/0.8ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-03-27 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-005 | LOVENOX (PRESERVATIVE FREE) | 100MG/ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 1998-03-27 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-006 | LOVENOX (PRESERVATIVE FREE) | 90MG/0.6ML (150MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / SUBCUTANEOUS | RLD | 2000-06-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N020164-007 | LOVENOX (PRESERVATIVE FREE) | 120MG/0.8ML (150MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 2000-06-02 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-008 | LOVENOX (PRESERVATIVE FREE) | 150MG/ML (150MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 2000-06-02 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-009 | LOVENOX | 300MG/3ML (100MG/ML) | INJECTABLE / INTRAVENOUS, SUBCUTANEOUS | AB | RLD | 2003-01-23 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-001 | LOVENOX (PRESERVATIVE FREE) | 30MG/0.3ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1993-03-29 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-002 | LOVENOX (PRESERVATIVE FREE) | 40MG/0.4ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-01-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-003 | LOVENOX (PRESERVATIVE FREE) | 60MG/0.6ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-03-27 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-004 | LOVENOX (PRESERVATIVE FREE) | 80MG/0.8ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-03-27 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-005 | LOVENOX (PRESERVATIVE FREE) | 100MG/ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 1998-03-27 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-006 | LOVENOX (PRESERVATIVE FREE) | 90MG/0.6ML (150MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / SUBCUTANEOUS | RLD | 2000-06-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-007 | LOVENOX (PRESERVATIVE FREE) | 120MG/0.8ML (150MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 2000-06-02 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-008 | LOVENOX (PRESERVATIVE FREE) | 150MG/ML (150MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 2000-06-02 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-009 | LOVENOX | 300MG/3ML (100MG/ML) | INJECTABLE / INTRAVENOUS, SUBCUTANEOUS | AB | RLD | 2003-01-23 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-001 | LOVENOX (PRESERVATIVE FREE) | 30MG/0.3ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1993-03-29 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-002 | LOVENOX (PRESERVATIVE FREE) | 40MG/0.4ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-01-30 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-003 | LOVENOX (PRESERVATIVE FREE) | 60MG/0.6ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-03-27 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-004 | LOVENOX (PRESERVATIVE FREE) | 80MG/0.8ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-03-27 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-005 | LOVENOX (PRESERVATIVE FREE) | 100MG/ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 1998-03-27 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-006 | LOVENOX (PRESERVATIVE FREE) | 90MG/0.6ML (150MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE / SUBCUTANEOUS | RLD | 2000-06-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-007 | LOVENOX (PRESERVATIVE FREE) | 120MG/0.8ML (150MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 2000-06-02 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-008 | LOVENOX (PRESERVATIVE FREE) | 150MG/ML (150MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 2000-06-02 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-009 | LOVENOX | 300MG/3ML (100MG/ML) | INJECTABLE / INTRAVENOUS, SUBCUTANEOUS | AB | RLD | 2003-01-23 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-001 | LOVENOX (PRESERVATIVE FREE) | 30MG/0.3ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1993-03-29 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-002 | LOVENOX (PRESERVATIVE FREE) | 40MG/0.4ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-01-30 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-003 | LOVENOX (PRESERVATIVE FREE) | 60MG/0.6ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-03-27 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-004 | LOVENOX (PRESERVATIVE FREE) | 80MG/0.8ML (100MG/ML) | INJECTABLE / SUBCUTANEOUS | AP | RLD | 1998-03-27 | 6a471c1ec25d… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N020164-001 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020164-002 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020164-003 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020164-004 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020164-005 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020164-007 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020164-008 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020164-009 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-002 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-003 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-004 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-005 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-007 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-008 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020164-009 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-002 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-003 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-004 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-005 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-007 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-008 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020164-009 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-002 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-003 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-004 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-005 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-007 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-008 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020164-009 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-002 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-003 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-004 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-005 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-007 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-008 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020164-009 | AB | 1 | 6a471c1ec25d… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lovenox | ENOXAPARIN SODIUM | Sanofi-Aventis U.S. LLC | 5017a927-2a24-4f27-89f9-27c805bf7d59 | 2026-05-28 | Boxed warning, Warnings, Adverse reactions | 0075-0621-60 00075062160 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.